A Global Transport Exchange-Traded Fund Strategy
Posted on Saturday, August 9th, 2008 | In Exchange Traded Funds, Market Commentary
Contributed by: Mike Havrilla (http://mikehav.blogspot.com/) -
Investors are currently limited to the iShares Dow Jones Transports (IYT) as a transport ETF option with net assets of $698 million and 20 component stocks (stats as of 8/8/08 from the iShares website). The top five holdings account for 43.2% of invested assets and include the following: Burlington Northern Santa Fe (BNI, 10.7%), Union Pacific (UNP, 9.6%), FedEx (FDX, 9.1%), Overseas Shipholding Group (OSG, 6.9%), and United Parcel (UPS, 6.9%). In addition, the iShares Dow Transports ETF also includes three passenger airlines: AMR Corp. (AMR), Continental (CAL), and JetBlue (JBLU); although the combined weighting for these three companies is negligible; they represent an opportunity cost by occupying three positions in the fund and omit industry leader Southwest Airlines (LUV).
As evidence of increased commercial interest and product development of globally-focused transport ETFs among major ETF providers, the following ideas have recently been filed with the SEC: Claymore/Delta Global Shipping, PowerShares Global Transportation, and SPDR Transportation.
My strategy for a family of four global transport ETFs is outlined below with links provided to more details on the component index for each segment:
1.) Global Logistics PerformIdex – composite (30 stocks) blend of rails (8), maritime (8) , trucking (8), and air freight/delivery (6)
2.) Global Railroad BULLISHares – long rail transport
3.) Global Maritime BULLISHares – long waterway transport
4.) Global Airline BEARISHares – short passenger airlines
Last 5 posts by Mike Havrilla
- RxNews Recap: 01-27-10 Repros Therapeutics rockets on news of FDA meeting. GenVec sinks on offering - January 27th, 2010
- Albertis $12.8B Bid to Lease PA Turnpike Expires with No Deal - October 1st, 2008
- Congress Working Overtime: $634B Spending Bill and Bailout Plan - September 27th, 2008
- Pfizer is a Big Pharma Buy - September 24th, 2008
- Bristol-Myers Ups Bid to $62 for ImClone - September 23rd, 2008
![]() About Mike Havrilla (http://mikehav.blogspot.com/)
The MikeHav Market Blog provides investors with a free source of stock profiles, tools, and commentaries focused on carbon credits, the healthcare sector, exchange-traded funds (ETFs), and innovative companies across all industries.
I am a pharmacist and index developer who has been investing since August 1997 and freelance writing for investors since April 2007. I am also an avid runner since 1992 and have completed 18 marathons (26.2 miles) with a personal best time of 2 hours, 54 minutes.
I can be contacted via email at mikehavrx[at]yahoo[dot]com.
MikeHav Market Blog: www.mikehav.blogspot.com
MikeHav Market Blog RSS Feed: http://feedproxy.google.com/mikehavblog
Investment Web Domain Names [PDF]: www.geocities.com/mikehavrx/websites.pdf
Global Carbon Trading Index [PDF]: www.geocities.com/mikehavrx/ctindex.pdf |



The MikeHav Market Blog provides investors with a free source of stock profiles, tools, and commentaries focused on 
